ChainCatcher news, Jia Yueting stated that Faraday Future's $30 million investment in Qualigen Therapeutics (QLGN) has more than doubled its market capitalization, and this strategic investment is expected to be completed this week, with the encryption flywheel accelerating. On September 20, Faraday Future announced that it would strategically invest in Qualigen Therapeutics (NASDAQ: QLGN) through a $41 million PIPE transaction, which will be renamed CXC10 and transformed into a platform for encryption and Web3 business. The lineup of investors is strong, including not only Faraday Future and Jia Yueting personally but also Sign, a blockchain technology company that builds on-chain public infrastructure for governments and enterprises worldwide, providing secure solutions ranging from digital identity verification to Token distribution.
Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to
Disclaimer.
